Category

AUTOINMMUNE DISEASES

Home > Therapeutic Areas > AUTOINMMUNE DISEASES

Rodríguez-Lago I, Muñoz Núñez F, Lucendo AJ, De Lossada Juste A, Cabez A, de la Cuadra-Grande A, Oyagüez I, Monte-Boquet E

 

 

Cost-Effectiveness Analysis of Etrasimod compared with Biologic Therapies for the Treatment of Patients with Moderately-to-Severely Active Ulcerative Colitis in Spain
Pharmacoecon Open. 2025. doi: 10.1007/s41669-025-00619-6

Rodríguez-Lago I, Muñoz Núñez F, Lucendo AJ, De Lossada Juste A, Cabez A, de la Cuadra-Grande A, Oyagüez I, Monte-Boquet E

 

 

Cost-effectiveness analysis of etrasimod compared with biologic therapies for patients with moderate-to-severe active ulcerative colitis experienced to previous advanced therapies in Spain
United European Gastroenterology (UEG) Week. Berlin. 4-7 oct 2025

Cábez A, De Lossada A, Arruñada M, de la Cuadra-Grande A, Oyagüez I

 

 

Análisis coste-efectividad de etrasimod en el tratamiento de pacientes con colitis ulcerosa moderada-grave naïve a terapia avanzada en España
28 Reunión anual de la Asociación Española de Gastroenterología (AEG). Madrid. 12-14 mar 2025

POSTER

Chamorro-de-Vega E, Calvo A, Fernández-Pacheco M, Hernández-Muniesa B, Romero-Jiménez R, Casado-Gómez A, Ramírez E, Grupo de Trabajo Estudio SACVINFA:; Morell A, Herrero N, Úbeda B, Ais-Larisgoitia A, Lobato-Matilla E, Muñoz Á, Casado MÁ, Escudero-Vilaplana V

Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study
Farmacia Hospitalaria. 2024 Nov-Dec;48(6):265-271

Valdez-Acosta S, Zubiaur P, Casado MA, Novalbos J, Casajús A, Campodónico D, Oyagüez I, Abad-Santos F

 

 

Preemptive TPMT genotyping and adherence to genotyping-based therapeutic recommendations reduces the healthcare cost in patients receiving azathioprine or 6-mercaptopurine for autoimmune diseases
J. Pers. Med. 2023, 13, 1208

Joven B, Hernández Sánchez R, Pérez-Pampín E, Aragón Díez A, Almodóvar R, Martínez-Ferrer A, Belzunegui J, Rubio E, Díaz-Cerezo S, Moyano S, Gómez-Barrera M, Yébenes M, Núñez M

 

Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
Rheumatol Ther. 2023 Oct;10(5):1319-1333

García-Olmo D, Gómez-Barrera M, de la Portilla F

 

 

 

Surgical management of complex perianal fistula revisited in a systematic review: a critical view of available scientific evidence
BMC Surgery. (2023) 23:29

Calvo García A, Chamorro de Vega E, Romero Jiménez R, Fernández Pacheco García-Valdecasas M, Herrero Muñoz N, Muñoz Cuadrado A, Casado Gómez A, Ramírez Herráiz E

 

Evaluación de la calidad de vida percibida por pacientes con enfermedades inflamatorias inmunomediadas en tratamiento con terapias biológicas y pequeñas moléculas dirigidas
67 Congreso Nacional de la SEFH. Barcelona. 24-26 nov 2022

Ramírez E, Romero-Jiménez R, Hernández B, Fernández-Pacheco M, Calvo A, Chamorro E, Herrero N, Úbeda B, Morell A, Ais-Larisgoitia A, Lobato-Matilla E, Muñoz Á, Casado A, Casado MÁ, Escudero-Vilaplana V

 

Evaluation of the hospital care quality perceived by patients with immune-mediated inflammatory diseases from the pharmacy service. SACVINFA study
J Clin Pharm Ther. 2022;1–10
1 2 3 9